Martin C. Michel

25.9k total citations · 4 hit papers
522 papers, 18.7k citations indexed

About

Martin C. Michel is a scholar working on Molecular Biology, Urology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Martin C. Michel has authored 522 papers receiving a total of 18.7k indexed citations (citations by other indexed papers that have themselves been cited), including 217 papers in Molecular Biology, 203 papers in Urology and 114 papers in Cellular and Molecular Neuroscience. Recurrent topics in Martin C. Michel's work include Urinary Bladder and Prostate Research (201 papers), Receptor Mechanisms and Signaling (162 papers) and Neuropeptides and Animal Physiology (83 papers). Martin C. Michel is often cited by papers focused on Urinary Bladder and Prostate Research (201 papers), Receptor Mechanisms and Signaling (162 papers) and Neuropeptides and Animal Physiology (83 papers). Martin C. Michel collaborates with scholars based in Germany, Netherlands and United States. Martin C. Michel's co-authors include Otto‐Erich Brodde, Paul A. Insel, Μ. Goepel, Wim Vrydag, Harvey Motulsky, Jean de la Rosette, Stephan L.M. Peters, Tim Schneider, Angela Bischoff and Christopher R. Chapple and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Circulation.

In The Last Decade

Martin C. Michel

511 papers receiving 18.0k citations

Hit Papers

EAU Guidelines on the Treatment and Fol... 1998 2026 2007 2016 2013 1998 1999 2013 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
    2013 916 citations Martin C. Michel et al. profile →
  2. XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y, Peptide YY, and Pancreatic Polypeptide Receptors
    1998 736 citations Martin C. Michel et al. profile →
  3. Adrenergic and Muscarinic Receptors in the Human Heart
    1999 507 citations Martin C. Michel et al. profile →
  4. The Molecular Basis for the Pharmacokinetics and Pharmacodynamics of Curcumin and Its Metabolites in Relation to Cancer
    2013 457 citations Martin C. Michel et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin C. Michel Germany 68 6.8k 6.4k 3.8k 3.0k 2.8k 522 18.7k
Alan J. Wein United States 72 2.4k 0.4× 11.8k 1.8× 676 0.2× 6.8k 2.2× 1.6k 0.6× 695 22.3k
Gozoh Tsujimoto Japan 70 9.6k 1.4× 869 0.1× 2.5k 0.7× 371 0.1× 2.8k 1.0× 336 18.0k
Matthias Endres Germany 81 6.8k 1.0× 137 0.0× 2.4k 0.6× 1.1k 0.4× 755 0.3× 560 24.1k
Edwin K. Jackson United States 71 5.8k 0.9× 155 0.0× 1.6k 0.4× 238 0.1× 2.4k 0.9× 502 19.4k
James K. Liao United States 96 11.5k 1.7× 139 0.0× 1.4k 0.4× 889 0.3× 4.5k 1.6× 280 35.1k
Michael Spedding France 65 11.7k 1.7× 158 0.0× 8.4k 2.2× 306 0.1× 1.4k 0.5× 231 24.4k
Pamela J. Shaw United Kingdom 89 9.8k 1.4× 187 0.0× 5.2k 1.4× 339 0.1× 269 0.1× 486 29.4k
Margaret Warner Sweden 70 5.1k 0.7× 231 0.0× 1.1k 0.3× 255 0.1× 2.7k 1.0× 206 18.3k
Tadashi Inagami United States 92 16.1k 2.4× 201 0.0× 2.9k 0.8× 294 0.1× 9.0k 3.2× 536 30.9k
Thomas J. Schnitzer United States 62 1.3k 0.2× 189 0.0× 921 0.2× 5.1k 1.7× 377 0.1× 242 18.6k

Countries citing papers authored by Martin C. Michel

Since Specialization
Citations

This map shows the geographic impact of Martin C. Michel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin C. Michel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin C. Michel more than expected).

Fields of papers citing papers by Martin C. Michel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin C. Michel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin C. Michel. The network helps show where Martin C. Michel may publish in the future.

Co-authorship network of co-authors of Martin C. Michel

This figure shows the co-authorship network connecting the top 25 collaborators of Martin C. Michel. A scholar is included among the top collaborators of Martin C. Michel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin C. Michel. Martin C. Michel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lederer, Ann‐Kathrin & Martin C. Michel. (2024). Natural Products in the Treatment of Lower Urinary Tract Dysfunction and Infection. Handbook of experimental pharmacology. 287. 295–323. 2 indexed citations
2.
Wojnowski, Leszek, et al.. (2024). A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2023. Naunyn-Schmiedeberg s Archives of Pharmacology. 397(5). 2949–2970. 3 indexed citations
3.
Meineck, Myriam, et al.. (2023). A systematic review on renal effects of SGLT2 inhibitors in rodent models of diabetic nephropathy. Pharmacology & Therapeutics. 249. 108503–108503. 11 indexed citations
4.
Meineck, Myriam, et al.. (2023). A Systematic Review on Renal Effects of Sglt2 Inhibitors in Rodent Models of Diabetic Nephropathy. SSRN Electronic Journal. 1 indexed citations
5.
Fornara, Paolo, et al.. (2022). Associations between the Patient Perception of Bladder Condition score and overactive bladder syndrome symptoms at baseline and upon treatment. Neurourology and Urodynamics. 41(6). 1399–1405. 3 indexed citations
6.
Wojnowski, Leszek, et al.. (2022). A year in pharmacology: new drugs approved by the US Food and Drug Administration in 2021. Naunyn-Schmiedeberg s Archives of Pharmacology. 395(8). 867–885. 16 indexed citations
7.
Michel, Martin C., et al.. (2021). Statistical inference in abstracts of 3 influential clinical pharmacology journals analysed using a text‐mining algorithm. British Journal of Clinical Pharmacology. 87(11). 4173–4182. 2 indexed citations
8.
9.
Igawa, Yasuhiko, Naoki Aizawa, & Martin C. Michel. (2019). β3‐Adrenoceptors in the normal and diseased urinary bladder—What are the open questions?. British Journal of Pharmacology. 176(14). 2525–2538. 39 indexed citations
10.
Michel, Martin C., et al.. (2018). Evidence-based management of overactive bladder patients: Expectation to become symptom-free. Neurourology and Urodynamics. 1 indexed citations
11.
Heijman, Jordi, Martina B. Michel-Reher, Niels Voigt, et al.. (2017). Muscarinic type-1 receptors contribute to I K,ACh in human atrial cardiomyocytes and are upregulated in patients with chronic atrial fibrillation. International Journal of Cardiology. 255. 61–68. 23 indexed citations
12.
Wagg, Adrian, Vik Khullar, Daniela Marschall‐Kehrel, et al.. (2011). Efficacy and Tolerability of Fesoterodine in Older People With Overactive Bladder: Results of the Open-Label Phase of the SOFIA Trial. 1 indexed citations
13.
Hendriks‐Balk, Mariëlle, et al.. (2009). Sphingosine-1-phosphate regulates RGS2 and RGS16 mRNA expression in vascular smooth muscle cells. European Journal of Pharmacology. 606(1-3). 25–31. 7 indexed citations
14.
Michel, Martin C. & Wim Vrydag. (2006). α1‐, α2‐ and β‐adrenoceptors in the urinary bladder, urethra and prostate. British Journal of Pharmacology. 147(S2). S88–119. 345 indexed citations
15.
Michel, Martin C., Maurits M. Barendrecht, & Matthias Oelke. (2006). [Anticholinergics for overactive bladder: does subtype selectivity play a role?].. Urologe A. 45(7). 826–829. 4 indexed citations
16.
Barendrecht, Maurits M., Paul Chichester, Martin C. Michel, & Robert M. Levin. (2006). Effect of short‐term outlet obstruction on rat bladder nerve density and contractility. Autonomic and Autacoid Pharmacology. 27(1). 47–53. 30 indexed citations
17.
18.
Bischoff, Angela & Martin C. Michel. (1998). Neuropeptide Y Lowers Blood Glucose in Anaesthetized Rats via a Y5Receptor Subtype. Endocrinology. 139(6). 3018–3021. 13 indexed citations
19.
Michel, Martin C. & Armin Buschauer. (1992). Neuropeptide Y and its antagonists. Biochemical and Biophysical Research Communications. 304(3). 433–5. 2 indexed citations
20.
Maisel, Alan S., Kirk U. Knowlton, Ann Rearden, et al.. (1990). Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment.. Journal of Clinical Investigation. 85(2). 462–467. 124 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan J. Wein Breakdown of academic impact, for papers by Gozoh Tsujimoto Breakdown of academic impact, for papers by Matthias Endres Breakdown of academic impact, for papers by Edwin K. Jackson Breakdown of academic impact, for papers by James K. Liao Breakdown of academic impact, for papers by Michael Spedding Breakdown of academic impact, for papers by Pamela J. Shaw Breakdown of academic impact, for papers by Margaret Warner Breakdown of academic impact, for papers by Tadashi Inagami Breakdown of academic impact, for papers by Thomas J. Schnitzer
Rankless by CCL
2026